MedTrace Logo

A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation Therapy

NCT02096484 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-10-17

No results posted yet for this study

Summary

The study will examine the effectiveness of group metacognitive therapy in comparison with group meditation therapy, in patients with Generalised Anxiety Disorder. Individuals will be randomly assigned to either meditation or metacognitive therapy and undergo 8 group therapy sessions of their respective treatment condition.

Conditions

  • Generalized Anxiety Disorder

Interventions

BEHAVIORAL

Group Metacognitive Therapy

BEHAVIORAL

Mindfulness Meditation Therapy

Sponsors & Collaborators

  • University of Manchester

    lead OTHER

Principal Investigators

  • Lora Capobianco · University of Manchester

  • James Thompson · University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-12-31
Completion
2016-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02096484 on ClinicalTrials.gov